[ad_1] WUHU, Chine, 21 oct. 2024 /PRNewswire/ — Le 20 octobre, M. Ban Ki-moon, 8ème Secrétaire général des Nations Unies et Président de la Fondation Ban Ki-moon, s’est rendu à Wuhu, en Chine, pour participer à la […]
Tag: Ltd
Ping An Reports Steady Growth in Operating Profit, Robust Increases in Net Profit and Life & Health NBV in 9M 2024
[ad_1] HONG KONG and SHANGHAI, Oct. 21, 2024 /PRNewswire/ — Ping An Insurance (Group) Company of China, Ltd. (hereafter “Ping An“, or the “Group”, HKEX: 2318 / 82318; SSE: 601318) today announced its results for the […]
JinkoSolar’s Subsidiary Jiangxi Jinko Proposed to Offer and List up to 1,000,519,986 A Shares in the Form of GDRs on the Frankfurt Stock Exchange in Germany
[ad_1] SHANGRAO, China, Oct. 21, 2024 /PRNewswire/ — JinkoSolar Holding Co., Ltd. (“JinkoSolar” or the “Company”) (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that Jinko […]
Portuguese Transplant Center Analysis of First 100 Cases of Hypothermic Oxygenated PErfusion (HOPE) in Liver Transplantation Demonstrates Increased Use of Marginal Grafts, Making More Livers Available for Transplantation USA – English USA – English
[ad_1] The analysis is being presented this week at the American College of Surgeons Clinical Congress 2024 (ACS 2024) in San Francisco, California, October 19-22, 2024 CHICAGO, Oct. 21, 2024 /PRNewswire/ — Bridge to Life […]
Foresee Pharmaceuticals Announces Preliminary Results from a Phase 1 Clinical Trial, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile of Linvemastat (FP-020), a Novel and Selective MMP-12 Inhibitor.
[ad_1] TAIPEI, Oct. 20, 2024 /PRNewswire/ — Foresee Pharmaceuticals (TPEx: 6576), (“Foresee”) today announced the successful completion of its Phase 1 single and multiple ascending dose (SAD/MAD) clinical study in Australia with linvemastat (FP-020), its […]
